DK Life Science Co., Ltd. (KOSDAQ:303810)

DK Life Science Statistics

Total Valuation

DK Life Science has a market cap or net worth of KRW 138.81 billion. The enterprise value is 166.45 billion.

Market Cap	138.81B
Enterprise Value	166.45B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

DK Life Science has 31.98 million shares outstanding. The number of shares has increased by 47.63% in one year.

Current Share Class	31.98M
Shares Outstanding	31.98M
Shares Change (YoY)	+47.63%
Shares Change (QoQ)	+114.42%
Owned by Insiders (%)	13.68%
Owned by Institutions (%)	n/a
Float	10.61M

Valuation Ratios

The trailing PE ratio is 8.91.

PE Ratio	8.91
Forward PE	n/a
PS Ratio	1.03
PB Ratio	1.08
P/TBV Ratio	1.13
P/FCF Ratio	44.61
P/OCF Ratio	16.90
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.04, with an EV/FCF ratio of 53.49.

EV / Earnings	20.66
EV / Sales	1.24
EV / EBITDA	9.04
EV / EBIT	13.56
EV / FCF	53.49

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.30.

Current Ratio	2.40
Quick Ratio	1.73
Debt / Equity	0.30
Debt / EBITDA	2.12
Debt / FCF	12.52
Interest Coverage	7.02

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	8.09%
Revenue Per Employee	1.34B
Profits Per Employee	80.55M
Employee Count	100
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DK Life Science has paid 2.62 billion in taxes.

Income Tax	2.62B
Effective Tax Rate	24.54%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	5,815.20
200-Day Moving Average	n/a
Relative Strength Index (RSI)	33.71
Average Volume (20 Days)	186,381

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DK Life Science had revenue of KRW 134.14 billion and earned 8.05 billion in profits. Earnings per share was 487.14.

Revenue	134.14B
Gross Profit	30.25B
Operating Income	12.27B
Pretax Income	10.67B
Net Income	8.05B
EBITDA	18.41B
EBIT	12.27B
Earnings Per Share (EPS)	487.14

Balance Sheet

The company has 11.31 billion in cash and 38.96 billion in debt, giving a net cash position of -27.64 billion or -864.24 per share.

Cash & Cash Equivalents	11.31B
Total Debt	38.96B
Net Cash	-27.64B
Net Cash Per Share	-864.24
Equity (Book Value)	128.11B
Book Value Per Share	4,005.31
Working Capital	75.96B

Cash Flow

In the last 12 months, operating cash flow was 8.22 billion and capital expenditures -5.10 billion, giving a free cash flow of 3.11 billion.

Operating Cash Flow	8.22B
Capital Expenditures	-5.10B
Free Cash Flow	3.11B
FCF Per Share	97.29

Margins

Gross margin is 22.55%, with operating and profit margins of 9.15% and 6.00%.

Gross Margin	22.55%
Operating Margin	9.15%
Pretax Margin	7.96%
Profit Margin	6.00%
EBITDA Margin	13.72%
EBIT Margin	9.15%
FCF Margin	2.32%

Dividends & Yields

DK Life Science does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-47.63%
Shareholder Yield	n/a
Earnings Yield	5.80%
FCF Yield	2.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 7, 2025. It was a forward split with a ratio of 2.

Last Split Date	Aug 7, 2025
Split Type	Forward
Split Ratio	2

Scores

DK Life Science has an Altman Z-Score of 2.78 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.78
Piotroski F-Score	5